3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M.
Tabouret E, et al. Among authors: brandal p.
Neuro Oncol. 2024 Jul 5;26(7):1302-1309. doi: 10.1093/neuonc/noae037.
Neuro Oncol. 2024.
PMID: 38452246
Clinical Trial.